LYMPHOPROLIFERATIVE DISORDER side effect
What is LYMPHOPROLIFERATIVE DISORDER ?Drugs associated with LYMPHOPROLIFERATIVE DISORDER
ALDURAZYME ATGAM AZATHIOPRINE BUSULFAN CASPOFUNGIN CELLCEPT CYCLOPHOSPHAMIDE CYCLOSPORINE ENBREL FLUDARA FLUDARABINE HUMIRA INFLIXIMAB MERCAPTOPURINE METHOTREXATE METHYLPREDNISOLO MICARDIS PREDNISOLONE PREDNISONE PROGRAF REMICADE SOMATROPIN TACROLIMUS THYMOGLOBULIN TYSABRILYMPHOPROLIFERATIVE DISORDER : Prednisolone Side Effects Report #5671630-4
Consumer or non-health professional from UNITED KINGDOM reported PREDNISOLONE problem on Feb 26, 2008. Male patient, 35 years of age, was diagnosed with renal transplant and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . PREDNISOLONE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, CYCLOSPORINE. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Cyclosporine Side Effects Report #5688592-6
CYCLOSPORINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2008. Female patient, 52 years of age, was diagnosed with lung transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, zygomycosis, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISOLONE, SIMULECT. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Humira Side Effects Report #5602730-2
Consumer or non-health professional from FRANCE reported HUMIRA problem on Jan 23, 2008. Male patient, weighting 160.9 lb, was diagnosed with rheumatoid arthritis, hypothyroidism, hypertension, antibiotic prophylaxis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . HUMIRA dosage: unknown. During the same period patient was treated with COMMERCIAL HUMIRA, LEVOTHYROXINE, METHOTREXATE, PREDNISONE, IRBESARTAN, RIFINAH. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Somatropin Side Effects Report #5577221-8
SOMATROPIN problem was reported by a Physician from UNITED STATES on Dec 20, 2007. Female patient was diagnosed with growth retardation and was treated with SOMATROPIN. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . SOMATROPIN dosage: 1.2 MG, QD. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Humira Side Effects Report #5522029-2
Consumer or non-health professional from FRANCE reported HUMIRA problem on Nov 15, 2007. Male patient, weighting 160.9 lb, was diagnosed with rheumatoid arthritis, hypothyroidism, hypertension, antibiotic prophylaxis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . HUMIRA dosage: unknown. During the same period patient was treated with COMMERCIAL HUMIRA, LEVOTHYROXINE, METHOTREXATE, PREDNISONE, IRBESARTAN, RIFINAH. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prograf Side Effects Report #5531785-9
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 12, 2007. Male patient, child 6 years of age, weighting 50.71 lb, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, respiratory rate increased, tonsillar hypertrophy, . PROGRAF dosage: unknown. During the same period patient was treated with ZENAPAX. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Caspofungin Side Effects Report #5470940-3
Consumer or non-health professional from UNITED STATES reported CASPOFUNGIN MSD problem on Sept 19, 2007. Male patient, 30 years of age, was diagnosed with fungal infection and was treated with CASPOFUNGIN MSD. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, multi-organ failure, . CASPOFUNGIN MSD dosage: unknown. During the same period patient was treated with CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, CASPOFUNGIN MSD, FLUCONAZOLE. Patient was hospitalized. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Cyclosporine Side Effects Report #5421951-5
CYCLOSPORINE problem was reported by a Consumer or non-health professional from ITALY on Aug 14, 2007. Female patient was diagnosed with immunosuppression and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . CYCLOSPORINE dosage: 4-40 MG/KG/DAY. During the same period patient was treated with AZATHIOPRINE. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Tacrolimus Side Effects Report #5376912-1
Physician from CANADA reported TACROLIMUS problem on June 27, 2007. Female patient, weighting 128.5 lb, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . TACROLIMUS dosage: unknown. During the same period patient was treated with ZENAPAX, PREDNISONE, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Atgam Side Effects Report #5423710-6
ATGAM problem was reported by a Physician from AUSTRIA on Jan 27, 2006. Male patient, 27 years of age, was diagnosed with heart transplant and was treated with ATGAM. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . ATGAM dosage: unknown. During the same period patient was treated with CYCLOSPORINE, GANCICLOVIR, MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Tacrolimus Side Effects Report #5376912-1
Physician from CANADA reported TACROLIMUS problem on June 27, 2007. Female patient, weighting 128.5 lb, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . TACROLIMUS dosage: unknown. During the same period patient was treated with ZENAPAX, PREDNISONE, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Atgam Side Effects Report #5423710-6
ATGAM problem was reported by a Physician from AUSTRIA on Jan 27, 2006. Male patient, 27 years of age, was diagnosed with heart transplant and was treated with ATGAM. After drug was administered, patient experienced the following problems/side effects: lymphoproliferative disorder, . ATGAM dosage: unknown. During the same period patient was treated with CYCLOSPORINE, GANCICLOVIR, MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Remicade Side Effects Report #5659550-2
Physician from FRANCE reported REMICADE problem on Feb 29, 2008. Male patient, 21 years of age, was diagnosed with crohn's disease, nutritional support and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . REMICADE dosage: unknown. During the same period patient was treated with NOVATREX, SOLUPRED, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prograf Side Effects Report #5663894-8
PROGRAF problem was reported by a Health Professional from FRANCE on Feb 15, 2008. Male patient, child 8 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: evans syndrome, lymphoproliferative disorder, no therapeutic response, pancytopenia, parvovirus infection, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, IMMUNOGLOBULINS, CORTICOSTEROID NOS, RITUXIMAB. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prograf Side Effects Report #5671749-8
Physician from UNITED STATES reported PROGRAF problem on Mar 06, 2008. Male patient, 22 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: haemoptysis, lymphoproliferative disorder, pulmonary embolism, transplant rejection, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE, PIPERACILLIN, TOBRAMYCIN, VANCOMYCIN HYDROCHLORIDE. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Mercaptopurine Side Effects Report #5675047-8
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2008. Female patient, child 4 years of age, was diagnosed with malignant histiocytosis and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . MERCAPTOPURINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE, VINBLASTINE SULPHATE, CLADRIBINE, CYTARABINE, METHOTREXATE. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Busulfan Side Effects Report #5679929-2
Consumer or non-health professional from CANADA reported BUSULFAN problem on Mar 13, 2008. Female patient was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . BUSULFAN dosage: 3.2 MG/KG; X1; IV. During the same period patient was treated with FLUDARABINE. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Busulfan Side Effects Report #5679930-9
BUSULFAN problem was reported by a Consumer or non-health professional from CANADA on Mar 13, 2008. Female patient was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . BUSULFAN dosage: 3.2 MG/KG; X1; IV. During the same period patient was treated with FLUDARABINE. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Remicade Side Effects Report #5619966-7
Physician from FRANCE reported REMICADE problem on Jan 30, 2008. Male patient was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prograf Side Effects Report #5626052-9
PROGRAF problem was reported by a Consumer or non-health professional from JAPAN on Feb 08, 2008. Female patient, 56 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: lymphoma, lymphoproliferative disorder, malaise, pneumonia, renal cell carcinoma, . PROGRAF dosage: unknown. During the same period patient was treated with CELLCEPT, METHYLPREDNISOLONE, SIMULECT. Patient died on 01/01/2006.
LYMPHOPROLIFERATIVE DISORDER : Prograf Side Effects Report #5630351-4
Consumer or non-health professional from JAPAN reported PROGRAF problem on Feb 15, 2008. Female patient, 56 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: lymphoma, lymphoproliferative disorder, malaise, pneumonia, renal cell carcinoma, . PROGRAF dosage: 3 MG/DAY. During the same period patient was treated with CELLCEPT, METHYLPREDNISOLONE, SIMULECT, RITUXIMAB. Patient died on 05/09/2006.
LYMPHOPROLIFERATIVE DISORDER : Fludarabine Side Effects Report #5635348-6
FLUDARABINE problem was reported by a Health Professional from CANADA on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Fludarabine Side Effects Report #5635370-X
Health Professional from CANADA reported FLUDARABINE problem on Feb 12, 2008. Female patient was diagnosed with bone marrow conditioning regimen, convulsion prophylaxis, prophylaxis against graft versus host disease, infection prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, lymphoproliferative disorder, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, PHENYTOIN, METHOTREXATE, CYCLOSPORINE, RABBIT ANTITHYMOCYTE GLOBULIN, ACYCLOVIR, TRIMETHOPRIM. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Methotrexate Side Effects Report #5588158-2
METHOTREXATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 27, 2007. Male patient, 66 years of age, weighting 143.3 lb, was diagnosed with ankylosing spondylitis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus test positive, lymphoproliferative disorder, . METHOTREXATE dosage: unknown. During the same period patient was treated with REMICADE, AMITRIPTYLINE, ANUSOL, ESOMEPRAZOLE, INDOMETHACIN, NIFEDIPINE. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prednisone Side Effects Report #5592374-3
Health Professional from JAPAN reported PREDNISONE problem on Jan 03, 2008. Female patient, child 1 years of age, was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: diffuse large b-cell lymphoma stage iv, lymphoproliferative disorder, . PREDNISONE dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Cellcept Side Effects Report #5592994-6
CELLCEPT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Male patient, weighting 271.2 lb, was diagnosed with prophylaxis against transplant rejection and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: asthenia, lymphoproliferative disorder, speech disorder, . CELLCEPT dosage: 250MG TWICE DAILY PO. During the same period patient was treated with PROGRAF. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Remicade Side Effects Report #5541451-1
Health Professional from UNITED KINGDOM reported REMICADE problem on Nov 29, 2007. Male patient, weighting 143.3 lb, was diagnosed with ankylosing spondylitis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus test positive, lymphoproliferative disorder, neoplasm, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, AMITRIPTLINE, ANUSOL, ESOMEPRAZOLE, INDOMETHACIN, NIFEDIPINE. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prograf Side Effects Report #5541520-6
PROGRAF problem was reported by a Physician from JAPAN on Nov 27, 2007. Male patient, 34 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: ascites, lymphoproliferative disorder, melaena, no therapeutic response, pancreatitis, . PROGRAF dosage: unknown. During the same period patient was treated with IMURAN, PREDNISOLONE. Patient died on 06/08/2007.
LYMPHOPROLIFERATIVE DISORDER : Prednisone Side Effects Report #5512360-9
Health Professional from INDIA reported PREDNISONE problem on Oct 22, 2007. Male patient, 31 years of age, was diagnosed with discomfort, eosinophilia, pain and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: hepatosplenomegaly, lymphoproliferative disorder, multi-organ failure, sepsis, strongyloidiasis, . PREDNISONE dosage: 20 MG QD PO. During the same period patient was treated with PREDNISOLONE PHOSPHATE, RANITIDINE. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Prednisone Side Effects Report #5517636-7
PREDNISONE problem was reported by a Consumer or non-health professional from on Nov 08, 2007. Female patient, child 1 years of age, was diagnosed with immunosuppression, prophylaxis, evidence based treatment, transplant rejection and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: diffuse large b-cell lymphoma stage iv, lymphoproliferative disorder, pancytopenia, peritonitis, transplant rejection, viral dna test positive, . PREDNISONE dosage: unknown. During the same period patient was treated with TACROLIMUS, RITUXIMAB, ACYCLOVIR, ANTIBIOTICS, GANCICLOVIR, METHYLPREDNISOLONE, CYCLOSPORINE. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Methotrexate Side Effects Report #5480925-9
Health Professional from UNITED KINGDOM reported METHOTREXATE problem on Sept 25, 2007. Male patient, 78 years of age, was diagnosed with rheumatoid arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: angiocentric lymphoma, lymphoproliferative disorder, . METHOTREXATE dosage: unknown. During the same period patient was treated with INFLIXIMAB. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prograf Side Effects Report #5487325-6
PROGRAF problem was reported by a Health Professional from NEW ZEALAND on Sept 28, 2007. Female patient, child 3 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: burkitt's lymphoma, lymphoproliferative disorder, . PROGRAF dosage: 1.25 MG, BID, ORAL. Patient died on 09/28/2007.
LYMPHOPROLIFERATIVE DISORDER : Infliximab Side Effects Report #5468413-7
Health Professional from UNITED KINGDOM reported INFLIXIMAB problem on Sept 18, 2007. Male patient, 78 years of age, was diagnosed with rheumatoid arthritis and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: arthritis, lymphoproliferative disorder, . INFLIXIMAB dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Methotrexate Side Effects Report #5420925-8
METHOTREXATE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Male patient, 71 years of age, was diagnosed with rheumatoid arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, lymphoproliferative disorder, . METHOTREXATE dosage: INCREASED TO 8 MG/WEEK.. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Methotrexate Side Effects Report #5423490-4
Consumer or non-health professional from UNITED STATES reported METHOTREXATE problem on Aug 21, 2007. Male patient, 71 years of age, was diagnosed with rheumatoid arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, lymphoproliferative disorder, . METHOTREXATE dosage: INCREASED TO 8 MG/WEEK.. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Thymoglobulin Side Effects Report #5388863-7
THYMOGLOBULIN problem was reported by a Health Professional from UNITED STATES on June 26, 2007. Male patient, 47 years of age, weighting 259.7 lb, was diagnosed with liver transplant, preoperative care and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma, lymphoproliferative disorder, renal failure acute, . THYMOGLOBULIN dosage: 189 MG QD IV. During the same period patient was treated with PROGRAF, PREDNISONE, SULFATRIM, VALCYTE, PROTONIX. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Thymoglobulin Side Effects Report #5423749-0
Health Professional from POLAND reported THYMOGLOBULIN problem on June 24, 2004. Female patient, 38 years of age, weighting 127.9 lb, was diagnosed with stem cell transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . THYMOGLOBULIN dosage: 0.5 MG/KG DAILY IV. During the same period patient was treated with TREOSULFAN, FLUDARABINE PHOSPHATE, CYCLOSPORINE, METHOTREXATE. Patient died on 05/10/2004.
LYMPHOPROLIFERATIVE DISORDER : Thymoglobulin Side Effects Report #5388863-7
THYMOGLOBULIN problem was reported by a Health Professional from UNITED STATES on June 26, 2007. Male patient, 47 years of age, weighting 259.7 lb, was diagnosed with liver transplant, preoperative care and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma, lymphoproliferative disorder, renal failure acute, . THYMOGLOBULIN dosage: 189 MG QD IV. During the same period patient was treated with PROGRAF, PREDNISONE, SULFATRIM, VALCYTE, PROTONIX. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Thymoglobulin Side Effects Report #5423749-0
Health Professional from POLAND reported THYMOGLOBULIN problem on June 24, 2004. Female patient, 38 years of age, weighting 127.9 lb, was diagnosed with stem cell transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . THYMOGLOBULIN dosage: 0.5 MG/KG DAILY IV. During the same period patient was treated with TREOSULFAN, FLUDARABINE PHOSPHATE, CYCLOSPORINE, METHOTREXATE. Patient died on 05/10/2004.
LYMPHOPROLIFERATIVE DISORDER : Azathioprine Side Effects Report #5663528-2
AZATHIOPRINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 26, 2008. Male patient, 35 years of age, was diagnosed with renal transplant and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, light chain analysis abnormal, lymphoproliferative disorder, skin lesion, skin nodule, . AZATHIOPRINE dosage: 100 MG; DAILY, 100 MG; DAILY. During the same period patient was treated with CYCLOSPORINE, PREDNISOLONE. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Tacrolimus Side Effects Report #5679940-1
Health Professional from POLAND reported TACROLIMUS problem on Mar 06, 2008. Female patient, 36 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: coagulopathy, haemodialysis, lymphoproliferative disorder, renal failure, subileus, upper respiratory tract infection, . TACROLIMUS dosage: unknown. During the same period patient was treated with ENCORTON. Patient was hospitalized. Patient died on 04/07/2006.
LYMPHOPROLIFERATIVE DISORDER : Micardis Side Effects Report #5685111-5
MICARDIS problem was reported by a Physician from JAPAN on Mar 25, 2008. Female patient, 74 years of age, weighting 108.0 lb, was diagnosed with rheumatoid arthritis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, histiocytosis haematophagic, lymphoproliferative disorder, . MICARDIS dosage: unknown. During the same period patient was treated with RHEUMATREX, FOLIAMIN, PROGRAF, PREDONINE, LOXONIN, NORVASC, TAKEPRON. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Tysabri Side Effects Report #5689471-0
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Mar 17, 2008. Female patient, 59 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: dementia, lymphoma, lymphoproliferative disorder, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Azathioprine Side Effects Report #5691968-4
AZATHIOPRINE problem was reported by a Consumer or non-health professional from FRANCE on Mar 12, 2008. Female patient, child 5 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, histiocytosis haematophagic, lymphoproliferative disorder, multi-organ failure, . AZATHIOPRINE dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Cyclophosphamide Side Effects Report #5537921-2
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Dec 05, 2007. Female patient, 15 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis, aspergillosis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, epstein-barr virus infection, lymphoproliferative disorder, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with THIOTEPA, RABBIT ANTITHYMOCYTE GLOBULIN, ORTHOCLONE OKT, HEPARIN, IMMUNE GLOBULIN, METRONIDAZOLE, AMPHOTERICIN B, AMPHOTERICIN B. Patient was hospitalized. Patient died.
LYMPHOPROLIFERATIVE DISORDER : Methylprednisolo Side Effects Report #5541919-8
METHYLPREDNISOLONE problem was reported by a Consumer or non-health professional from JAPAN on Nov 23, 2007. Male patient, child 11 years of age, was diagnosed with immunosuppression and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic function abnormal, lymphoproliferative disorder, transaminases increased, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with MIZORIBINE, TACROLIMUS. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Remicade Side Effects Report #5522945-1
Physician from GERMANY reported REMICADE problem on Nov 12, 2007. Female patient, child 5 years of age, was diagnosed with uveitis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, cataract, lymphoproliferative disorder, . REMICADE dosage: 5-6 MG/KG. During the same period patient was treated with METHOTREXATE, DECORTIN, NAPROXEN, CORTISONE ACETATE. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Fludara Side Effects Report #5477830-0
FLUDARA problem was reported by a Physician from FRANCE on Sept 20, 2007. Male patient, 68 years of age, was diagnosed with t-cell prolymphocytic leukaemia and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: b-cell lymphoma, histiocytosis haematophagic, lymphoproliferative disorder, . FLUDARA dosage: 50 MG/D, D1-D3. During the same period patient was treated with CYCLOPHOSPHAMIDE, CAMPATH. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prednisone Side Effects Report #5493751-1
Consumer or non-health professional from reported PREDNISONE problem on Oct 16, 2007. Female patient, 58 years of age, was diagnosed with vasculitis, diffuse large b-cell lymphoma and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: cushingoid, epstein-barr virus infection, lymphoproliferative disorder, muscular weakness, . PREDNISONE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, HYDROXYCHLOROQUINE SULPHATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, CORTICOSTEROIDS, METHYLPREDNISOLONE, RITUXIMAB. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Prograf Side Effects Report #5504744-X
PROGRAF problem was reported by a Physician from JAPAN on Oct 17, 2007. Male patient, 38 years of age, weighting 108.0 lb, was diagnosed with lung transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, lymphoproliferative disorder, no therapeutic response, pneumonia, pseudarthrosis, staphylococcal osteomyelitis, sternal fracture, transplant rejection, . PROGRAF dosage: 2 MG, BID,ORAL; 1.75 MGSEE IMAGE. Patient was hospitalized. Patient recovered.
LYMPHOPROLIFERATIVE DISORDER : Enbrel Side Effects Report #5463081-2
Health Professional from UNITED STATES reported ENBREL problem on Sept 10, 2007. Male patient was diagnosed with psoriasis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, leukocytosis, lymphoproliferative disorder, platelet count decreased, . ENBREL dosage: unknown. Patient recovered.